Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I8BO
|
||||
| Former ID |
DNC013997
|
||||
| Drug Name |
1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529594] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H37NO3
|
||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CO2
|
||||
| InChI |
1S/C25H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-22(27)25-26-21-24(29-25)23-19-17-20-28-23/h9-10,17,19-21H,2-8,11-16,18H2,1H3/b10-9-
|
||||
| InChIKey |
RZGSPAWMLKONHZ-KTKRTIGZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529594] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.